Semaglutide: Reference Overview and Reconstitution Notes

Semaglutide is a GLP-1 receptor agonist peptide (a lab-made molecule that activates a specific protein involved in metabolism and weight control). It falls under metabolic and weight-regulation research. It is FDA-approved for specific uses, including type 2 diabetes and chronic weight management.

What it is

Semaglutide is a lab-made copy of a natural body signal called GLP-1 (glucagon-like peptide-1). Think of GLP-1 as a chemical messenger your body releases after eating. It tells other parts of the body to manage blood sugar and reduce hunger. Semaglutide is built to stay active much longer than the natural version. That is why research literature often discusses it as a once-a-week injectable or as an oral (swallowed) form.

Research context and categorization

Semaglutide belongs to the metabolic and weight-regulation research category. Scientists study it in connection with GLP-1 receptor signaling (the process by which GLP-1 carries its messages to cells). Research topics include blood sugar control, insulin release (insulin is the hormone that helps cells absorb sugar from the blood), how fast the stomach empties, and how the body signals hunger and fullness.

Investigational Areas

Beyond its approved uses, semaglutide is the subject of active investigational research (studies exploring new possible uses). Researchers have looked at its effects on cardiovascular and kidney outcomes (heart and kidney health). It is also being studied in connection with non-alcoholic steatohepatitis (NASH), a liver condition caused by excess fat buildup in liver cells.

A growing body of work also looks at GLP-1 receptor agonists in relation to addiction and craving. This includes trials on alcohol use disorder. Researchers also study it in relation to brain protection and neurodegenerative conditions (diseases where brain cells break down over time), because GLP-1 receptors are found on several types of brain cells. These broader areas are exploratory and are not confirmed or approved outcomes.

Status

• Regulatory status: FDA-approved for specific uses, including blood sugar control in type 2 diabetes, chronic weight management, and reducing certain cardiovascular and kidney risks. It is marketed under brand names such as Ozempic, Wegovy, and Rybelsus.
• Sport status: Semaglutide is not specifically listed as prohibited on the 2026 WADA Prohibited List (WADA is the World Anti-Doping Agency, which sets rules about substances in sport). However, semaglutide (along with tirzepatide) was added to the WADA Monitoring Program starting January 1, 2026. This means its markers are being tracked in and out of competition to watch for possible misuse. Monitoring means surveillance, not a ban. Its status could change in future List updates.

Reconstitution notes (general)

Lyophilized (freeze-dried) peptides come as a powder. To use them in the lab, you add liquid and mix them into a solution. This is called reconstitution. The working concentration (how strong the solution is) comes from a simple calculation: milligrams of peptide in the vial divided by millilitres of liquid added. Think of it like mixing a powdered drink: less water means a stronger mix.

For example, 5 mg of powder mixed with 2 mL of bacteriostatic water gives 2.5 mg/mL. To calculate a target concentration or the right volume of water, use the calculator at peptide calculator.

Dilution and handling notes (compound-specific)

For research purposes, semaglutide often comes as a lyophilized powder in vials of 5 mg or 10 mg. A common approach is to mix a 5 mg vial with about 2 mL to 2.5 mL of bacteriostatic water. This produces concentrations of roughly 2 mg/mL to 2.5 mg/mL. Smaller 2 mg vials mixed with 2 mL yield about 1 mg/mL.

Bacteriostatic water is purified water that contains a small amount of benzyl alcohol as a preservative. That preservative allows multiple withdrawals from the same vial over time without contaminating it. Plain sterile water does not offer this protection, so bacteriostatic water is generally the better choice for multi-use vials.

Key point: After mixing, the semaglutide solution should look clear and colorless. Discard it right away if it appears cloudy, has any color, or contains visible particles floating in it.

Reconstitution Steps & Handling

Semaglutide dissolves easily and usually clears within about a minute of gentle swirling. It does not need the more forceful steps that some harder-to-dissolve peptides require.

Because it can foam up if handled roughly, use this technique at the bench:

• Direct the water slowly down the inner wall of the vial instead of aiming it straight onto the powder.
• Swirl gently rather than shaking. Too much agitation can stress the peptide and create foam, which makes accurate measurement harder.

Note that oral tablet forms of semaglutide come ready to use and do not need mixing. These handling notes apply only to the lyophilized powder form.

Handling and storage

Store the mixed solution in a refrigerator at 2 to 8 degrees Celsius (about 36 to 46 degrees Fahrenheit), away from direct light. Wipe the rubber stopper with an alcohol swab before each withdrawal. Write the mix date on the vial label so you can track how long it has been stored.

A mixed solution is commonly treated as usable for about four weeks when kept refrigerated. Discard the solution if it turns cloudy, changes color, or shows any floating particles.

Related reading

• Teriparatide
• Tesamorelin
• Tirzepatide
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What research areas does semaglutide cover?

Semaglutide is a GLP-1 receptor agonist studied in metabolic signaling, blood sugar regulation, cardiovascular and kidney outcomes, liver conditions (NASH), addiction, and neurodegeneration. It is FDA-approved for type 2 diabetes and weight management.

How do you calculate concentration when reconstituting a lyophilized peptide?

Divide peptide mass (mg) by diluent volume (mL). For example, 5 mg dissolved in 2 mL bacteriostatic water yields 2.5 mg/mL. Use a peptide calculator to confirm the exact diluent volume needed for any target concentration.

Is semaglutide on the WADA prohibited list?

Semaglutide is not currently prohibited by WADA but was added to the 2026 Monitoring Program alongside tirzepatide, meaning its markers are tracked in and out of competition for surveillance purposes. Its status may change in future List updates.

More in our bacteriostatic water and diluents collection.

What the research community gets wrong about semaglutide

• Assuming every vial gives the same concentration. The strength of your solution depends only on the milligrams in the vial divided by the millilitres of water you add. A 5 mg vial and a 10 mg vial filled with the same volume are not the same strength. Always run the math for the vial in front of you.
• Shaking the vial to dissolve it faster. Semaglutide clears with gentle swirling in about a minute. Hard shaking makes foam and adds shear stress at the air and liquid surface, which can stress the peptide and make accurate measurement harder.
• Treating bacteriostatic water and plain sterile water as the same thing. Bacteriostatic water carries a small amount of benzyl alcohol as a preservative, so a vial can handle repeated withdrawals. Plain sterile water has no preservative and is a poorer choice for a multi-use vial.
• Thinking a clear solution proves the strength is correct. Clear and colorless only tells you the powder dissolved. It says nothing about concentration. The concentration still comes from your mass and volume numbers, not from how the liquid looks.
• Believing a mixed vial keeps forever if it stays cold. A reconstituted solution is commonly treated as usable for about four weeks refrigerated. Label the mix date, and discard the vial if it turns cloudy, changes color, or shows floating particles.

From our bench: Next time you reconstitute a semaglutide vial, time how many seconds of gentle swirling it takes for the powder to fully clear, and note whether any foam formed on the surface. Record the vial size, the water volume you added, and the room temperature. Send us your numbers and we will add real bench observations to this page.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem: Semaglutide (CID 56843331), NIH National Library of Medicine
5. Ozempic (semaglutide) injection label, FDA/DailyMed
6. Singh G, et al. Wegovy (semaglutide): a new weight loss drug for chronic weight management. J Investig Med, 2022 (PMID 34706925)